Dolby Laboratories, Inc. (DLB) Major Shareholder Sells $6,572,000.00 in Stock

Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock in a transaction dated Tuesday, April 16th. The stock was sold at an average price of $65.72, for a total value of $6,572,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Friday, April 12th, Dagmar Dolby sold 96,567 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.22, for a total value of $6,298,099.74.
  • On Thursday, March 21st, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.06, for a total value of $3,253,000.00.
  • On Tuesday, March 12th, Dagmar Dolby sold 21,465 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.00, for a total value of $1,395,225.00.
  • On Monday, March 4th, Dagmar Dolby sold 2,406 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.05, for a total value of $156,510.30.
  • On Friday, March 1st, Dagmar Dolby sold 95,963 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.05, for a total value of $6,242,393.15.
  • On Wednesday, February 27th, Dagmar Dolby sold 98,543 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.24, for a total value of $6,428,945.32.
  • On Monday, February 25th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.67, for a total value of $3,283,500.00.
  • On Thursday, February 21st, Dagmar Dolby sold 69,885 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.32, for a total value of $4,564,888.20.
  • On Tuesday, February 19th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.41, for a total value of $3,270,500.00.
  • On Friday, February 15th, Dagmar Dolby sold 401 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.00, for a total value of $26,065.00.

Shares of Dolby Laboratories stock opened at $64.60 on Friday. Dolby Laboratories, Inc. has a one year low of $58.17 and a one year high of $72.04. The stock has a market capitalization of $6.63 billion, a P/E ratio of 26.92, a PEG ratio of 2.26 and a beta of 0.87.

Dolby Laboratories (NYSE:DLB) last issued its earnings results on Wednesday, January 30th. The electronics maker reported $0.93 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.40. Dolby Laboratories had a return on equity of 11.30% and a net margin of 25.47%. The business had revenue of $302.40 million during the quarter, compared to analyst estimates of $295.04 million. During the same period in the previous year, the company posted ($0.80) EPS. The firm’s revenue was up 1.0% compared to the same quarter last year. On average, equities analysts anticipate that Dolby Laboratories, Inc. will post 2.24 earnings per share for the current fiscal year.

A number of institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its position in Dolby Laboratories by 4.0% in the 3rd quarter. Vanguard Group Inc. now owns 5,508,279 shares of the electronics maker’s stock valued at $385,415,000 after buying an additional 209,633 shares in the last quarter. Vanguard Group Inc increased its position in Dolby Laboratories by 4.0% in the 3rd quarter. Vanguard Group Inc now owns 5,508,279 shares of the electronics maker’s stock valued at $385,415,000 after buying an additional 209,633 shares in the last quarter. BlackRock Inc. increased its position in Dolby Laboratories by 12.4% in the 3rd quarter. BlackRock Inc. now owns 2,924,015 shares of the electronics maker’s stock valued at $204,594,000 after buying an additional 323,489 shares in the last quarter. Disciplined Growth Investors Inc. MN increased its position in Dolby Laboratories by 11.4% in the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 1,497,157 shares of the electronics maker’s stock valued at $104,756,000 after buying an additional 152,940 shares in the last quarter. Finally, Timucuan Asset Management Inc. FL increased its position in Dolby Laboratories by 0.7% in the 4th quarter. Timucuan Asset Management Inc. FL now owns 1,254,775 shares of the electronics maker’s stock valued at $77,595,000 after buying an additional 8,753 shares in the last quarter. 56.39% of the stock is owned by institutional investors and hedge funds.

A number of research analysts have recently issued reports on the company. ValuEngine downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Monday, April 1st. Zacks Investment Research downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Thursday, January 17th. Finally, Barrington Research reissued a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research note on Thursday, January 31st. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Dolby Laboratories has an average rating of “Buy” and a consensus target price of $75.75.

COPYRIGHT VIOLATION NOTICE: This news story was first posted by WKRB News and is owned by of WKRB News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of United States and international copyright laws. The legal version of this news story can be read at https://www.wkrb13.com/2019/04/20/dolby-laboratories-inc-dlb-major-shareholder-sells-6572000-00-in-stock.html.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.

See Also: Dividend Achievers

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.